INFU

$9.83

Post-MarketAs of Mar 17, 8:00 PM UTC

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada.

OverviewIntradayAnalysisPROIntelligencePROAsk AIPRO

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$9.83
Potential Downside
36%
Whystock Fair Value$6.30
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Devices

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic a...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$199.90M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
31.71
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.63
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
11.54%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
1.35

Recent News

GuruFocus.com
Feb 26, 2026

InfuSystems Holdings Inc (INFU) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...

InfuSystems Holdings Inc (INFU) reports a robust 7% revenue increase and significant debt reduction, while navigating challenges in contract restructuring and cost pressures.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Moby
Feb 24, 2026

InfuSystem Holdings, Inc. Q4 2025 Earnings Call Summary

Moby summary of InfuSystem Holdings, Inc.'s Q4 2025 earnings call

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
Zacks
Feb 24, 2026

InfuSystems Holdings, Inc. (INFU) Q4 Earnings Beat Estimates

InfuSystems Holdings (INFU) delivered earnings and revenue surprises of +53.85% and -0.74%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Feb 19, 2026

ICU Medical (ICUI) Q4 Earnings and Revenues Surpass Estimates

ICU Medical (ICUI) delivered earnings and revenue surprises of +13.52% and +1.32%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Feb 5, 2026

Prestige Consumer Healthcare (PBH) Q3 Earnings Lag Estimates

Prestige Consumer Healthcare (PBH) delivered earnings and revenue surprises of -1.30% and +0.48%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

BEARISH
Negative press. News cycle fixated on risk factors or misses.